Incidence and predictors of abdominal pain after transarterial chemoembolization of hepatocellular carcinoma: a single-center retrospective study.

PURPOSE: To assess the incidence and predictive factors of abdominal pain following transarterial hepatic chemoembolization (TACE) in patients with hepatocellular carcinoma. METHODS: In this single-center retrospective cohort study, abdominal pain was defined as a score of 4 or more within 72 h after TACE and requiring additional drug intervention. Patient, tumor characteristics, and technical factors associated with severe pain were identified using the decision tree and binary logistic regression model. RESULTS: Of 220 patients who were included in the study, 126 (57.3%) had abdominal pain after 206 of 420 TACE procedures (49.0%). A predictive model built based on the logistic regression identified the drug-eluting bead TACE (DEB-TACE) (odds ratio [OR] = 3.340; 95% confidence interval [CI] 2.169-5.141), the number of tumors (OR = 2.235; 95% CI 1.060-4.713), embolization of both hepatic lobes (OR = 2.310; 95% CI 1.109-4.813), and concomitant extrahepatic artery embolism (OR = 2.654; 95% CI 1.227-5.739) as the independent predictors of severe abdominal pain. Similarly, the decision tree confirmed the DEB-TACE as the strongest predictor of subsequent performance, followed by the history of hepatectomy and the embolization in the right or both lobes. The area under the receiver operating characteristic curve (AUC) of the classification prediction effect of the two models was 0.706 for the logistic regression and 0.676 for the decision tree. Internal validation results show that the accuracy of logistic regression model prediction was 71.4%. CONCLUSION: The model suggests that DEB-TACE and multiple treatment sites are predictors of abdominal pain after TACE in patients with hepatocellular carcinoma. It may help improve nursing management practices.

[Cadmium Accumulation Characteristics of Different Heat Varieties Under Cadmium Stress].

In order to provide technical support for the safe utilization of heavy metal-polluted farmland, we screened wheat varieties with a low accumulation of Cd in grain via a pot experiment. For this purpose, we respectively investigated the enrichment and transport characteristics of Cd in various plant parts of 119 wheat varieties under the conditions of 1.5 mg·kg-1 (low content) and 4.0 mg·kg-1 (high content) Cd-contaminated soil and explored the correlation between the Cd content of different organs of wheat and the relationship between Cd content in soil and the uptake of Cd by wheat. The results showed that:① there were significant differences in the ability to accumulate and transport Cd in roots, stems, leaves, and grains of tested wheat varieties (P<0.05). Under the condition of low Cd content, the Cd enrichment ability of each part of the wheat plant was as follows:leaf>stem ≈root>grain; under high-content stress conditions, the Cd enrichment ability of each part of the wheat plant was:leaf>root>stem>grain; under different content conditions, the Cd transport ability of each part of the wheat plant was:leaf>stem>grain. Cd content in the wheat shoot was positively correlated with total Cd content and ion-exchangeable Cd content in soil (P<0.01) and was closely related to strong transpiration under the pot experiment. ② The correlation coefficient r of BCFCd of wheat roots, stems, leaves, and grain was -0.267 to -0.645, showing a very significant negative correlation (P<0.01), indicating that with the increase in soil Cd content, the migration and accumulation degree of Cd in wheat plant organs showed a downward trend. Moreover, the negative correlation between BCFCd and soil Cd content in stems was significantly higher than that in roots, leaves, and grains, indicating that the enrichment of Cd in wheat plants largely depended on the accumulation and transportation of stems. ③ The correlation coefficient r of Cd content between the root and stem, root and leaf, root and grain, stem and leaf, stem and grain, and leaf and grain in low-and high-content groups was 0.450-0.763, showing a very significant positive correlation (P<0.01), indicating that there was a close transport relationship among the wheat organs, and the degree of translocation from the root to stem and stem to leaf was higher than that from the stem to grain and leaf to grain. ④ Using cluster analysis and enrichment and translocation coefficient sequencing, this study screened 16 and 11 wheat varieties with low Cd accumulation under the soil cadmium content of 1.5 mg·kg-1and 4.0 mg·kg-1, respectively. Among them, Luohan 7 could be used as the optimal wheat variety with low Cd accumulation under the conditions of low-, medium-, and high-Cd content.

Neuroprotective Effects of Lycium barbarum Berry on Neurobehavioral Changes and Neuronal Loss in the Hippocampus of Mice Exposed to Acute Ionizing Radiation.

Background: Brain exposure to ionizing radiation during the radiotherapy of brain tumor or metastasis of peripheral cancer cells to the brain has resulted in cognitive dysfunction by reducing neurogenesis in hippocampus. The water extract of Lycium barbarum berry (Lyc), containing water-soluble Lycium barbarum polysaccharides and flavonoids, can protect the neuronal injury by reducing oxidative stress and suppressing neuroinflammation. Reseach Design: To demonstrate the long-term radioprotective effect of Lyc, we evaluated the neurobehavioral alterations and the numbers of NeuN, calbindin (CB), and parvalbumin (PV) immunopositive hippocampal neurons in BALB/c mice after acute 5.5 Gy radiation with/without oral administration of Lyc at the dosage of 10 g/kg daily for 4 weeks. Results: The results showed that Lyc could improve irradiation-induced animal weight loss, depressive behaviors, spatial memory impairment, and hippocampal neuron loss. Immunohistochemistry study demonstrated that the loss of NeuN-immunopositive neuron in the hilus of the dentate gyrus, CB-immunopositive neuron in CA1 strata radiatum, lacunosum moleculare and oriens, and PV-positive neuron in CA1 stratum pyramidum and stratum granulosum of the dentate gyrus after irradiation were significantly improved by Lyc treatment. Conclusion: The neuroprotective effect of Lyc on those hippocampal neurons may benefit the configuration of learning related neuronal networks and then improve radiation induced neurobehavioral changes such as cognitive impairment and depression. It suggests that Lycium barbarum berry may be an alternative food supplement to prevent radiation-induced neuron loss and neuropsychological disorders.

p-Terphenyls and actinomycins from a Streptomyces sp. associated with the larva of mud dauber wasp.

In the course of searching for cytotoxic metabolites from insects associated actinomyces, two new natural p-terphenyl glycosides, strepantibin D (1) and strepantibin E (2), along with terferol (3), actinomycin D (4), actinomycin V (5) and actinomycin V0ß (6), were identified from the fermentation medium of a Streptomyces sp. which was obtained from the larva body of mud dauber wasp. Strepantibin D (1), previously reported as a synthetic derivative of terfestatin A, is firstly isolated as a natural p-terphenyl in this research. Strepantibin D (1) and terferol (3) showed medium cytotoxic activity against breast cancer cells MCF-7, MDA-MB-231 and BT-474. Actinomycins (4-6), especially actinomycin V (5), displayed remarkable cytotoxicity against breast cancer cells, with IC50 values ranging from 0.83 nM to 369.90 nM.

The effects and mechanisms of a biosynthetic ginsenoside 3ß,12ß-Di-O-Glc-PPD on non-small cell lung cancer.

BACKGROUND: A biosynthetic ginsenoside, 3-O-ß-D-glucopyranosyl-12-O-ß-D-glucopyranosyl-dammar-24-ene-3ß, 12ß, 20S-triol (C3C12PPD), showed antitumor activity against many tumor cells in vitro, especially had better anti-lung cancer activity than Rg3 in vitro and in vivo. However, the effects and molecular mechanisms of C3C12PPD on non-small cell lung cancer (NSCLC) remain unclear. According to previous studies, we hypothesized ginsenoside C3C12PPD could inhibit the tumor growth of NSCLC by targeting proliferation, migration and angiogenesis. METHODS: A thiazolyl blue tetrazolium bromide assay (MTT) was performed to evaluate cell viability. Additionally, Transwell and tube formation assays were conducted to analyze cell migration and angiogenesis. The Lewis and A549 tumor xenograft experiments were also performed to investigate the effects of C3C12PPD on tumor growth in vivo, Western blotting and IHC assay were performed to analyze protein expression. RESULTS: C3C12PPD could effectively inhibit the proliferation and migration of lung cancer cells, and tube formation of EA.hy926 cell. Ginsenoside C3C12PPD suppressed Lewis and A549 tumor growth in vivo without obvious side effects on body weight and the hematology index. In addition, the Western blot analysis revealed that the effects of C3C12PPD on lung cancer were mediated by inhibiting Raf/MEK/ERK, AKT/mTOR and AKT/GSK-3ß/ß-Catenin signaling pathways. Finally, C3C12PPD could significantly inhibit the proliferation index and vessel number in Lewis xenograft tumors analyzed by IHC. CONCLUSION: The results of the present study suggest that ginsenoside C3C12PPD may serve as a potential therapeutic candidate compound against NSCLC.

Cytotoxic, Anti-Migration, and Anti-Invasion Activities on Breast Cancer Cells of Angucycline Glycosides Isolated from a Marine-Derived Streptomyces sp.

Four angucycline glycosides were previously characterized from marine-derived Streptomyces sp. OC1610.4. Further investigation of this strain cultured on different fermentation media from that used previously resulted in the isolation of two new angucycline glycosides, vineomycins E and F (1-2), and five known homologues, grincamycin L (3), vineomycinone B2 (4), fridamycin D (5), moromycin B (7), and saquayamycin B1 (8). Vineomycin F (2) contains an unusual ring-cleavage deoxy sugar. All the angucycline glycosides isolated from Streptomyces sp. OC1610.4 were evaluated for their cytotoxic activity against breast cancer cells MCF-7, MDA-MB-231, and BT-474. Moromycin B (7), saquayamycin B1 (8), and saquayamycin B (9) displayed potent anti-proliferation against the tested cell lines, with IC50 values ranging from 0.16 to 0.67 µM. Saquayamycin B (9) inhibited the migration and invasion of MDA-MB-231 cells in a dose-dependent manner, as detected by Transwell and wound-healing assays.

Combination of 5-deoxy-5-fluorouridine and tamoxifen show cell-type specific antagonistic and cooperative effects on cytotoxicity in human mammary carcinoma cells.

The effect of tamoxifen (Tam) and 5-deoxy-5-fluorouridine (5-DFUR) cotreatment on cytotoxicity was assessed in various cancer-derived cell lines. Each cell line was treated with a range of Tam and 5-DFUR concentrations alone and in combination. The cell lines we examined include MDA-MB-231 (ERalpha-/ERbeta+), T47D (ERalpha+/ERbeta+), and three MCF-7 (ERalpha+/ERbeta+) sublines. Cell growth was assessed by MTT assay at multiple time points for up to 9 days. Fluorescence-associated cell sorting (FACS) analysis was used to examine the effects of Tam and 5-DFUR cotreatment on cell cycle progression. Treatment with Tam or 5-DFUR, which is metabolized to 5-FU in target cells, produced an anti-proliferative effect that was dose- and time-dependent in all cell lines examined; variation in cell line sensitivity to each compound and cotreatment was apparent. When 5-DFUR and Tam treatment were combined, T47D, MDA-MB-231, and an MCF-7 subline demonstrated a cooperative effect at the lowest Tam concentration tested in 9-day cultures. The significance of treatment dosage and duration was obvious when 5-DFUR and Tam cotreatment was observed to be antagonistic in 3-day cultures of a second MCF-7 subline and T47D cells. Results from our studies show that there may be cytotoxic benefits in the treatment of cancer from combined therapy with Tam and 5-FU precursor drugs. Enhanced inhibition of proliferation was observed when Tam was cotreated at low concentrations in relatively long-term cultures. This has clinical relevance in that it suggests that patients undergoing chemo-endocrine therapy with orally administered 5-FU precursor drugs may benefit from lower treatment dosages relative to other adjuvant therapies.

Novel perspective: focusing on the X chromosome in reproductive cancers.

In an XX female, one of the two X chromosomes has been inactivated during early embryonic life to achieve a compensation of X-linked gene products between males and females, leaving only one allele of X-linked genes functional. There are some X-linked genes escaping the X-inactivation, i.e., being expressed from both alleles. Escape from X-inactivation varies at different levels; some genes have both alleles active in some women but only one allele active in others, whereas some other genes have both alleles active in neoplastic tissue but only one allele active normally. The X-inactivation may be considered functionally equivalent to a loss of heterozygosity (LOH) for some genes, whereas escape from X-inactivation may be equivalent to functional gene amplification for others. The physiological LOH may make X-linked tumor suppressor genes lose their function more easily, compared with autosomal tumor suppressor genes, thus predisposing women to cancer formation more easily. Moreover, the human X chromosome contains many genes related to cancer or to sex and reproduction. All these properties of the X chromosome suggest that it may play more important roles than any autosomal chromosome in the development and progression of reproductive and urologic cancers.